John Tatlock is currently the Director of Medicinal Chemistry at Iambic Therapeutics, a position they have held since 2025. Previously, they served as an Associate Research Fellow in Oncology Medicinal Chemistry at Pfizer from 1991 to 2025. With extensive experience in medicinal chemistry, John is dedicated to transforming ideas into effective drug therapies.
This person is not in any teams
This person is not in any offices